Magic mushroom compound tested as new hope for Tough-to-Treat OCD
NCT ID NCT06992999
Summary
This study is testing whether psilocybin, the active compound in 'magic mushrooms,' can help people with OCD when standard treatments haven't worked well enough. Twenty adults with moderate to severe OCD will be randomly assigned to receive either a low or high dose of psilocybin during four supervised sessions over 12 weeks. Researchers will measure changes in OCD symptoms, quality of life, and safety, while also using brain scans to understand how it might work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Arizona-Tucson
Tucson, Arizona, 85724, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.